MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients

BackgroundGenetic susceptibility plays an important role in the risk of developing pain in individuals with cancer. As a complex trait, multiple genes underlie this susceptibility. We used gene network analyses to identify novel target genes associated with pain in patients newly diagnosed with squamous cell carcinoma of the head and neck (HNSCC).ResultsWe first identified 36 cancer pain-related genes (i.e., focus genes) from 36 publications based on a literature search. The Ingenuity Pathway Analysis (IPA) analysis identified additional genes that are functionally related to the 36 focus genes through pathway relationships yielding a total of 82 genes. Subsequently, 800 SNPs within the 82 IPA-selected genes on the Illumina HumanOmniExpress-12v1 platform were selected from a large-scale genotyping effort. Association analyses between the 800 candidate SNPs (covering 82 genes) and pain in a patient cohort of 1368 patients with HNSCC (206 patients with severe pain vs. 1162 with non-severe pain) showed the highest significance for MAPK1/ERK2, a gene belonging to the MAP kinase family (rs8136867, p value = 8.92 × 10−4; odds ratio [OR] = 1.33, 95 % confidence interval [CI]: 1.13–1.58). Other top genes were PIK3C2G (a member of PI3K [complex], rs10770367, p value = 1.10 × 10−3; OR = 1.46, 95 % CI: 1.16–1.82), TCRA (the alpha chain of T-cell receptor, rs6572493, p value = 2.84 × 10−3; OR = 0.70, 95 % CI: 0.55–0.88), PDGFC (platelet-derived growth factor C, rs6845322, p value = 4.88 × 10−3; OR = 1.32, 95 % CI: 1.09–1.60), and CD247 (a member of CD3, rs2995082, p value = 7.79 × 10−3; OR = 0.76, 95 % CI: 0.62–0.93).ConclusionsOur findings provide novel candidate genes and biological pathways underlying pain in cancer patients. Further study of the variations of these candidate genes could inform clinical decision making when treating cancer pain.

[1]  Choon-Sik Park,et al.  A common intronic variant of CXCR3 is functionally associated with gene expression levels and the polymorphic immune cell responses to stimuli. , 2008, The Journal of allergy and clinical immunology.

[2]  A. Serretti,et al.  Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  B. Schmidt,et al.  Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery. , 2014, The journal of pain : official journal of the American Pain Society.

[4]  A. Díez-Pérez,et al.  Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study , 2013, Breast Cancer Research and Treatment.

[5]  Ole A. Andreassen,et al.  Gene-Based Analysis of Regionally Enriched Cortical Genes in GWAS Data Sets of Cognitive Traits and Psychiatric Disorders , 2012, PloS one.

[6]  Jian Wang,et al.  Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction , 2015, BMC Systems Biology.

[7]  S. Kaasa,et al.  Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain , 2008, Molecular pain.

[8]  J. Bai,et al.  Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cells , 2014, The Journal of pathology.

[9]  C. Sommer,et al.  Differential expression of cytokines in painful and painless neuropathies , 2007, Neurology.

[10]  R. Quirion,et al.  The ERK/MAPK pathway, as a target for the treatment of neuropathic pain , 2005, Expert opinion on therapeutic targets.

[11]  Calculating and Interpreting the p-values for Functions , Pathways and Lists in IPA Overview , 2010 .

[12]  C. Martin.  2015 , 2015, Les 25 ans de l’OMC: Une rétrospective en photos.

[13]  Jason H. Moore,et al.  Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing , 2012, Human Genetics.

[14]  K. Noguchi,et al.  Activation of p38 MAPK through transient receptor potential A1 in a rat model of gastric distension-induced visceral pain , 2013, Neuroreport.

[15]  M. Clark,et al.  Genetic variations and patient-reported quality of life among patients with lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. D'haese,et al.  The neurotrophic factor neurturin contributes toward an aggressive cancer cell phenotype, neuropathic pain and neuronal plasticity in pancreatic cancer. , 2014, Carcinogenesis.

[17]  Robert M. Plenge,et al.  Meta-Analysis of Genome-Wide Association Studies in Celiac Disease and Rheumatoid Arthritis Identifies Fourteen Non-HLA Shared Loci , 2011, PLoS genetics.

[18]  G. Shorten,et al.  Persistent pain after mastectomy with reconstruction. , 2011, Journal of clinical anesthesia.

[19]  Peter Z. Schochet.  Technical Methods Report: Guidelines for Multiple Testing in Impact Evaluations. NCEE 2008-4018. , 2008 .

[20]  S. Kalinin,et al.  A Single-Nucleotide Polymorphism in Serine-Threonine Kinase 11, the Gene Encoding Liver Kinase B1, Is a Risk Factor for Multiple Sclerosis , 2015, ASN neuro.

[21]  M. Spitz,et al.  Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes , 2013, Supportive Care in Cancer.

[22]  S. Blackshaw,et al.  Profiling the Human Protein-DNA Interactome Reveals ERK2 as a Transcriptional Repressor of Interferon Signaling , 2009, Cell.

[23]  R. Ji,et al.  MAP kinase and pain , 2009, Brain Research Reviews.

[24]  S. Koizumi,et al.  Activation of p38 mitogen‐activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury , 2004, Glia.

[25]  B. Fridley,et al.  Gene set analysis of SNP data: benefits, challenges, and future directions , 2011, European Journal of Human Genetics.

[26]  Cinzia Brunelli,et al.  Multiple Loci Modulate Opioid Therapy Response for Cancer Pain , 2011, Clinical Cancer Research.

[27]  E. Bruera,et al.  Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. , 2009, Journal of pain and symptom management.

[28]  P. Malfertheiner,et al.  Inhibition of p38 MAP kinase‐and RICK/NF‐κB‐signaling suppresses inflammatory bowel disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Yi Dai,et al.  Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats , 2004, The European journal of neuroscience.

[30]  Francisco E. Baralle,et al.  Genomic variants in exons and introns: identifying the splicing spoilers , 2004, Nature Reviews Genetics.

[31]  H. Hakonarson,et al.  Analysing biological pathways in genome-wide association studies , 2010, Nature Reviews Genetics.

[32]  R. Quirion,et al.  Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus , 2002, PAIN.

[33]  E. D. Crown.  The role of mitogen activated protein kinase signaling in microglia and neurons in the initiation and maintenance of chronic pain , 2012, Experimental Neurology.

[34]  Yi Dai,et al.  Activation of p38 MAPK in primary afferent neurons by noxious stimulation and its involvement in the development of thermal hyperalgesia , 2005, Pain.

[35]  S. Kaasa,et al.  The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease , 2004, Acta anaesthesiologica Scandinavica.

[36]  Jing Cui,et al.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci , 2010, Nature Genetics.

[37]  E. Bruera,et al.  Cytokine Genes and Pain Severity in Lung Cancer: Exploring the Influence of TNF-α-308 G/A IL6-174G/C and IL8-251T/A , 2007, Cancer Epidemiology Biomarkers & Prevention.

[38]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[39]  T. Rebbeck,et al.  Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors , 2011, Breast Cancer Research.

[40]  Yi Dai,et al.  Role of Mitogen-Activated Protein Kinase Activation in Injured and Intact Primary Afferent Neurons for Mechanical and Heat Hypersensitivity after Spinal Nerve Ligation , 2004, The Journal of Neuroscience.

[41]  M. Clark,et al.  SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. , 2012, Lung cancer.

[42]  A. Gottschalk,et al.  Natural Variation in the &mgr;-opioid Gene OPRM1 Predicts Increased Pain on Third Day After Thoracotomy , 2012, The Clinical journal of pain.

[43]  C. Woolf,et al.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.

[44]  M. Arroyo-Morales,et al.  Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors , 2012, Breast Cancer Research and Treatment.

[45]  Cai-yue Liu,et al.  The role of large-conductance, calcium-activated potassium channels in a rat model of trigeminal neuropathic pain , 2015, Cephalalgia : an international journal of headache.

[46]  J. Droney,et al.  Analgesia and central side-effects: two separate dimensions of morphine response. , 2013, British journal of clinical pharmacology.

[47]  M. Spitz,et al.  Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. , 2013, Journal of pain and symptom management.

[48]  B. Schmidt,et al.  Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery. , 2012, The journal of pain : official journal of the American Pain Society.

[49]  D. Campa,et al.  Association of ABCB1/MDR1 and OPRM1 Gene Polymorphisms With Morphine Pain Relief , 2008, Clinical pharmacology and therapeutics.

[50]  M. Martínez-ríos,et al.  The variant rs8048002 T>C in intron 3 of the MHC2TA gene is associated with risk of developing acute coronary syndrome. , 2015, Cytokine.

[51]  Daphne H. E. W. Huberts,et al.  Moonlighting proteins: an intriguing mode of multitasking. , 2010, Biochimica et Biophysica Acta.

[52]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[53]  S. Shete,et al.  Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. , 2014, The journal of pain : official journal of the American Pain Society.

[54]  S. Papson,et al.  “Model” , 1981 .

[55]  Melissa Bondy,et al.  Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.

[56]  Yusuke Nakamura,et al.  Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  K. Stankovic,et al.  Metabolomic and Network Analysis of Pharmacotherapies for Sensorineural Hearing Loss , 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[58]  Martha L Slattery,et al.  MAP kinase genes and colon and rectal cancer. , 2012, Carcinogenesis.

[59]  E. Bruera,et al.  Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene , 2007, PAIN.

[60]  S. Kaasa,et al.  The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients , 2005, Pain.

[61]  Gwyn McClelland.  Survivors , 1891, The Hospital.

[62]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[63]  S. Leal,et al.  Effect of Catechol-o-methyltransferase-gene (COMT) Variants on Experimental and Acute Postoperative Pain in 1,000 Women undergoing Surgery for Breast Cancer , 2013, Anesthesiology.

[64]  E. Bruera,et al.  The Influence of Tumor Necrosis Factor-α −308 G/A and IL-6 −174 G/C on Pain and Analgesia Response in Lung Cancer Patients Receiving Supportive Care , 2008, Cancer Epidemiology Biomarkers & Prevention.

[65]  C. Woolf,et al.  p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.

[66]  R. Galindo-Murillo,et al.  Whole Genome Gene Expression Analysis Reveals Casiopeína-Induced Apoptosis Pathways , 2013, PloS one.

[67]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[68]  Jiahuai Han,et al.  Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.

[69]  E. Bruera,et al.  Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[70]  K. Stankovic,et al.  A Comprehensive Network and Pathway Analysis of Human Deafness Genes , 2013, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[71]  P. Deloukas,et al.  Multiple common variants for celiac disease influencing immune gene expression , 2010, Nature Genetics.

[72]  R. Kreienberg,et al.  Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations , 1999, British Journal of Cancer.

[73]  R. Albert,et al.  The large-scale organization of metabolic networks , 2000, Nature.

[74]  M. Clark,et al.  Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors , 2010, Cancer.

[75]  A. Doehring,et al.  A GTP cyclohydrolase 1 genetic variant delays cancer pain , 2010, PAIN.

[76]  K. Fried,et al.  Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. , 2010, Genome research.

[77]  B. Schmidt,et al.  Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. , 2012, Cytokine.

[78]  Augusto Caraceni,et al.  Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. , 2002, Journal of pain and symptom management.

[79]  H. Kim,et al.  Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression. , 2012, The Biochemical journal.

[80]  C. Reyes-Gibby,et al.  Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.